GSK plc Reports Share Transactions

TL;DR

GSK buying back its own shares, filing shows.

AI Summary

GSK plc announced on August 27, 2025, that it has conducted transactions in its own shares. The filing, a Form 6-K, details these share repurchases as part of its ongoing program. This action reflects the company's capital allocation strategy and its management of outstanding share count.

Why It Matters

This filing indicates GSK is actively managing its share count, which can impact earnings per share and shareholder value.

Risk Assessment

Risk Level: low — The filing is a routine report of share transactions and does not contain new material financial or strategic information that would inherently increase risk.

Key Players & Entities

• GSK plc (company) — Registrant
• August 2025 (date) — Reporting period
• 001-15170 (other) — Commission File Number

FAQ

Filing Documents

• a7568w.htm (6-K) — 2550KB
• 0001654954-25-010072.txt ( ) — 2552KB

From the Filing

IN OWN SHARES a7568w UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934       For the month of August 2025   Commission File Number 001-15170     GSK plc (Translation of registrant's name into English)     79 New Oxford Street, London, WC1A 1DG (Address of principal executive office)       Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.   Form 20-F . . . .X. . . . Form 40-F . . . . . . . .                                     Transaction in own shares   GSK plc (the " Company ") announces today   acting through its corporate stockbroker, Merrill Lynch International (the " Broker "), it has purchased the following number of the Company's ordinary shares of  31¼  pence each.   Date of purchase:   26 August 2025   Aggregate number of ordinary shares of  31¼  pence each purchased:   251,452   Lowest price paid per share (GBp):   1,460.00p   Highest price paid per share (GBp):   1,487.50p   Volume-weighted average price paid per share (GBp):   1,469.66p     The purchased shares will be held as Treasury shares.   Such purchase forms part of the Company's existing buyback programme and was effected pursuant to the non-discretionary agreement entered into with the Broker on 4 June 2025, as announced on 4 June 2025. Since 4 June 2025 the Company has purchased 25,524,347 ordinary shares.   Following the above purchase, the Company will hold 243,658,730 ordinary shares in treasury and have 4,071,733,897 ordinary shares in issue (excluding Treasury shares).   The total number of voting rights in the Company is   4,071,733,897. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.   The Company confirms that, in accordance with DTR 5.5.1R, following the above purchase the percentage of voting rights attributable to the ordinary shares held in treasury is   5.98 per cent.   The table below contains detailed information of the individual trades made by the Broker on the London Stock Exchange and the CBOE Europe Limited recognised investment exchange (through its order books having market identification codes CHIX or BATE) as part of the buyback programme.     Schedule of Purchases   Shares purchased:      GSK plc (ISIN: GB00BN7SWP63)   Date of purchases:     26 August 2025   Investment firm:        Merrill Lynch International     Aggregated information per trading venue:   Venue   Number of ordinary shares purchased   Highest price paid (per ordinary share) (GBp)   Lowest price paid (per ordinary share) (GBp)   Volume weighted average price paid (per ordinary share) (GBp)   London Stock Exchange (XLON)   251,452   1,487.50p   1,460.00p   1,469.66p   CBOE (CHIX)   0   -   -   -   CBOE (BATE)   0   -   -   -       Individual transactions:   Number of Shares   Price per Share (GBp)   Trading venue   Date of transaction   Time of transaction   Transaction reference number   41   1,469.50    XLON   26-Aug-2025   08:00:25   0XL06700000000005MJ680   50   1,470.50    XLON   26-Aug-2025   08:00:25   0XL06700000000005MJ67V   19   1,469.00    XLON   26-Aug-2025   08:00:27   0XL06400000000005MJ677   29   1,469.00    XLON   26-Aug-2025   08:00:27   0XL06400000000005MJ676   47   1,469.00    XLON   26-Aug-2025   08:00:27   0XL06100000000005MJ62H   52   1,469.00    XLON   26-Aug-2025   08:00:27   0XL06A00000000005MJ6C1   53   1,469.00    XLON   26

View Full Filing

View this 6-K filing on SEC EDGAR